Achaogen Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
10,738.00
63,679.00
58,731.00
146,003.00
170,682.00
Total Accounts Receivable
7,230.00
5,234.00
5,039.00
12,151.00
1,357.00
Other Current Assets
1,873.00
520.00
1,719.00
2,189.00
2,050.00
Total Current Assets
19,841.00
69,433.00
65,489.00
160,343.00
174,089.00
Net Property, Plant & Equipment
743.00
725.00
905.00
3,261.00
14,810.00
Total Investments and Advances
127.00
127.00
127.00
250.00
3,855.00
Other Assets
47.00
37.00
342.00
71.00
4,317.00
Total Assets
20,758.00
70,322.00
66,863.00
163,925.00
197,071.00
ST Debt & Current Portion LT Debt
4,989.00
-
-
4,167.00
12,500.00
Accounts Payable
2,923.00
2,122.00
3,537.00
5,739.00
6,862.00
Other Current Liabilities
3,077.00
3,394.00
5,152.00
9,802.00
17,541.00
Total Current Liabilities
10,989.00
5,516.00
8,689.00
19,708.00
36,903.00
Long-Term Debt
1,698.00
-
14,536.00
21,110.00
9,457.00
Provision for Risks & Charges
-
-
-
13,874.00
9,774.00
Other Liabilities
369.00
193.00
479.00
2,498.00
8,975.00
Total Liabilities
13,056.00
5,709.00
23,704.00
57,190.00
65,109.00
Common Equity (Total)
124,576.00
64,613.00
43,159.00
106,735.00
121,962.00
Total Shareholders' Equity
7,702.00
64,613.00
43,159.00
106,735.00
131,962.00
Total Equity
7,702.00
64,613.00
43,159.00
106,735.00
131,962.00
Liabilities & Shareholders' Equity
20,758.00
70,322.00
66,863.00
163,925.00
197,071.00
Preferred Stock (Carrying Value)
132,278.00
-
-
-
10,000.00

About Achaogen

View Profile
Address
1 Tower Place
South San Francisco California 94080
United States
Employees -
Website http://www.achaogen.com
Updated 09/14/2018
Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E.